Article Versions Notes

Blukacz Ł, Nowak A, Wójtowicz M, Krawczyk A, Franik G, Madej P, Pluta D, Kowalczyk K, Żorniak M. Clinical Usefulness of Non-Invasive Metabolic-Associated Fatty Liver Disease Risk Assessment Methods in Patients with Full-Blown Polycystic Ovary Syndrome in Relation to the MRI Examination with the Ideal IQ Sequence. Biomedicines. 2022; 10(9):2193. https://doi.org/10.3390/biomedicines10092193

Blukacz, Łukasz, Artur Nowak, Mariusz Wójtowicz, Angelika Krawczyk, Grzegorz Franik, Paweł Madej, Dagmara Pluta, Karolina Kowalczyk, and Michał Żorniak. 2022. "Clinical Usefulness of Non-Invasive Metabolic-Associated Fatty Liver Disease Risk Assessment Methods in Patients with Full-Blown Polycystic Ovary Syndrome in Relation to the MRI Examination with the Ideal IQ Sequence" Biomedicines 10, no. 9: 2193. https://doi.org/10.3390/biomedicines10092193

Blukacz, Ł., Nowak, A., Wójtowicz, M., Krawczyk, A., Franik, G., Madej, P., Pluta, D., Kowalczyk, K., & Żorniak, M. (2022). Clinical Usefulness of Non-Invasive Metabolic-Associated Fatty Liver Disease Risk Assessment Methods in Patients with Full-Blown Polycystic Ovary Syndrome in Relation to the MRI Examination with the Ideal IQ Sequence. Biomedicines, 10(9), 2193. https://doi.org/10.3390/biomedicines10092193